Description: Presented at May 2002 Spring Meeting. Discusses the proposed new valuation table and how it affects future product development and design.

Description: Presented at May 1996 Spring Meeting. This session provides an update on current annuity financial reporting topics, including: status of annuity valuation law revisions and proposed Actuarial Guideline GGG.

Description: This panel discussed studies of the risk of loss due to changes in the interest rate environment. It addressed why the C-3 risk is important and how inflation and stability in interest rates can affect the financial soundness of life insurance companies. There was also a discussion of the theoretical work being carried out to calibrate the C-3 risk of variation in interest rates and to what extent the valuation actuary can properly recognize the risk of loss from changes in the interest rate environment within the framework of valuations laws and regulations.

Description: Presented at May 1985 Spring Meeting. This session discussed: Single premium deferred annuity, Flexible premium annuity, Universal life, Vanishing premium life, Indexed products, Variable products, Reinsurance.

Description: Presented at June 1985 Spring Meeting. Discusses statutory and GAAP accounting alternatives for Universal Life, Variable Products, Flexible Premium Annuity and Single Premium Deferred Annuity.

Description: Presented at April 1985 Spring Meeting. This session discussed different accounting alternatives for products such as Universal Life, deferred annuities, variable products.

Description: Presented at May 1985 Spring Meeting. Discusses: Statutory annual statement, Statement of actuarial opinion for interest-indexed universal life insurance, American Academy of Actuaries Financial Reporting Recommendation 7, Statement of opinion required by New York State for annuity products, Other required statements of actuarial opinion, The Valuation Actuary, Practical techniques and actual experiences.

Description: Presented at October 1996 Annual Meeting. This session focuses on implementation and regulatory interpretation issues.

Description: While this session was billed as C-2 risk, discussion focused almost entirely on HIV and AIDS, including the history, nature, spreading and mortality of the disease, and its impact on life and health insurance underwriting, pricing, and reserves. From the 1987 Record of Society of Actuaries, Vol. 13, No. 3.

Description: Presented at June 1985 Spring Meeting. This session discussion was an overview of the valuation actuary's role, product development implications, actuarial profession implications, implications for regulators, and implications for insurance company management in each country.